AstraZeneca PLC vs The Goldman Sachs Group, Inc.
Market cap comparison over time
AstraZeneca PLC
$282.7B
Rank #47
The Goldman Sachs Group, Inc.
$305.5B
Rank #44
Market Cap Over Time
Key Moments
- The Goldman Sachs Group, Inc. overtook AstraZeneca PLC by 2006
- AstraZeneca PLC overtook The Goldman Sachs Group, Inc. by 2008
- The Goldman Sachs Group, Inc. overtook AstraZeneca PLC by 2026
Year-by-Year Comparison
| Year | AstraZeneca PLC | The Goldman Sachs Group, Inc. | Leader |
|---|---|---|---|
| 2026 | $282.7B | $305.5B | The Goldman Sachs Group, Inc. |
| 2025 | $282.2B | $255.6B | AstraZeneca PLC |
| 2024 | $196.9B | $163.2B | AstraZeneca PLC |
| 2023 | $198.1B | $107.8B | AstraZeneca PLC |
| 2022 | $195.3B | $93.0B | AstraZeneca PLC |
| 2021 | $163.9B | $100.5B | AstraZeneca PLC |
| 2020 | $136.9B | $68.0B | AstraZeneca PLC |
| 2019 | $132.8B | $58.3B | AstraZeneca PLC |
| 2018 | $97.9B | $41.5B | AstraZeneca PLC |
| 2017 | $85.9B | $62.4B | AstraZeneca PLC |
| 2016 | $64.5B | $57.9B | AstraZeneca PLC |
| 2015 | $76.6B | $42.9B | AstraZeneca PLC |
| 2014 | $76.2B | $45.6B | AstraZeneca PLC |
| 2013 | $61.7B | $41.1B | AstraZeneca PLC |
| 2012 | $46.3B | $29.2B | AstraZeneca PLC |
| 2011 | $42.7B | $20.4B | AstraZeneca PLC |
| 2010 | $40.3B | $37.4B | AstraZeneca PLC |
| 2009 | $38.9B | $37.2B | AstraZeneca PLC |
| 2008 | $32.3B | $18.4B | AstraZeneca PLC |
| 2007 | $32.3B | $46.4B | The Goldman Sachs Group, Inc. |
| 2006 | $39.1B | $42.8B | The Goldman Sachs Group, Inc. |
| 2005 | $34.5B | $27.2B | AstraZeneca PLC |
| 2004 | $25.2B | $21.9B | AstraZeneca PLC |
| 2003 | $32.9B | $20.6B | AstraZeneca PLC |
| 2002 | $23.4B | $14.1B | AstraZeneca PLC |
| 2001 | $30.5B | $19.0B | AstraZeneca PLC |
| 2000 | $33.1B | $21.8B | AstraZeneca PLC |
| 1999 | $25.7B | $19.1B | AstraZeneca PLC |